Abstract:Background: Plasmid DNA (pDNA) is a promising molecule for therapeutic applications. pDNA is produced by Escherichia coli in high cell-density cultivations (HCDC) using fed-batch mode. The typical limitations of such cultivations, including metabolic deviations like aerobic acetate production due to the existence of substrate gradients in large-scale bioreactors, remain as serious challenges for fast and effective pDNA production. We have previously demonstrated that the substitution of the phosphotransferase system by the over-expressed galactose permease for glucose uptake in E. coli (strain VH33) allows efficient growth, while strongly decreases acetate production. In the present work, additional genetic modifications were made to VH33 to further improve pDNA production. Several genes were deleted from strain VH33: the recA, deoR, nupG and endA genes were inactivated independently and in combination. The performance of the mutant strains was evaluated in shake flasks for the production of a 6.1 kb plasmid bearing an antigen gene against mumps. The best producer strain was cultivated in lab-scale bioreactors using 100 g/L of glucose to achieve HCDC in batch mode. For comparison, the widely used commercial strain DH5α, carrying the same plasmid, was also cultivated under the same conditions. Results: The various mutations tested had different effects on the specific growth rate, glucose uptake rate, and pDNA yields (YP/X). The triple mutant VH33 Δ (recA deoR nupG) accumulated low amounts of acetate and resulted in the best YP/X (4.22 mg/g), whereas YP/X of strain VH33 only reached 1.16 mg/g. When cultivated at high glucose concentrations, the triple mutant strain produced 186 mg/L of pDNA, 40 g/L of biomass and only 2.2 g/L of acetate. In contrast, DH5α produced only 70 mg/L of pDNA and accumulated 9.5 g/L of acetate. Furthermore, the supercoiled fraction of the pDNA produced by the triple mutant was nearly constant throughout the cultivation. Conclusion: The pDNA concentration obtained with the engineered strain VH33 Δ (recA deoR nupG) is, to the best of our knowledge, the highest reported for a batch cultivation, and its supercoiled fraction remained close to 80%. Strain VH33 Δ (recA deoR nupG) and its cultivation using elevated glucose concentrations represent an attractive technology for fast and efficient pDNA production and a valuable alternative to fed-batch cultivations of commercial strains.

Production of Dimer Plasmid DNA by Recombinant Escherichia Coli

Enhanced D-Pantothenic Acid Biosynthesis by Plasmid-Free Escherichia Coli Through Sodium Pyruvate Addition Combined with Glucose and Temperature Control Strategy.

Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode

Inducible Escherichia coli fermentation for increased plasmid DNA production

High-Cell-Density Culture to Produce Plasmid DNA for Gene Therapy in E. coli

Heterologous erythromycin production across strain and plasmid construction

Enhanced Production of L-Tryptophan with Glucose Feeding and Surfactant Addition and Related Metabolic Flux Redistribution in the Recombinant Escherichia Coli

Increasing the Pentose Phosphate Pathway Flux to Improve Plasmid DNA Production in Engineered E. coli

Cloning,Analysis and Fusion Expression of Methyl Parathion Hydrolase

High‐level Production of Soluble Pyrroloquinoline Quinone‐dependent Glucose Dehydrogenase in Escherichia Coli

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

Function of YidC for the insertion of M13 procoat protein in Escherichia coli: translocation of mutants that show differences in their membrane potential dependence and Sec requirement.

An in vitro approach for production of non-scar minicircle DNA vectors.

A Continuous Process to Extract Plasmid DNA Based on Alkaline Lysis

High Kanamycin Concentration as Another Stress Factor Additional to Temperature to Increase pDNA Production in E. coli DH5α Batch and Fed-Batch Cultures

Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia Coli Vectors.

Optimization of fermentation conditions for an Escherichia coli strain engineered using the response surface method to produce a novel therapeutic DNA vaccine for rheumatoid arthritis

Optimization of medium composition for propagation of recombinant Escherichia coli

Escherichia coli plasmid production in fermenter

Cloning and Expression of Vitreoscilla Hemoglobin Gene in Recombinant Escherichia Coli to Produce Poly-Β-hydroxybutyrate (PHB)

Metabolic Engineering of Escherichia coli for Production of 2,5-Dimethylpyrazine